"We're still in discussions with the (UK) government to figure out what type of incentives there may be. We don't have ...

AstraZeneca did not immediately say whether any changes announced in the Budget influenced its negotiations with the ...

AstraZeneca boss Pascal Soriot (pictured)) threw his weight behind its Chinese business despite the recent arrest of its boss ...

AstraZeneca's £450 million investment plan for vaccine R&D in the UK is under review as discussions on governmental ...

London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...

London-listed drugmaker AstraZeneca said its plan to invest 650 million pounds ($833.2 million) in Britain for vaccine ...

AstraZeneca, the London-listed pharmaceutical company, has put its planned £650 million investment in UK vaccine research and ...

AstraZeneca, headquartered in Cambridge UK but globally influential, is investing $3.5 billion in the United States to expand ...

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the ...

AstraZeneca chief executive Pascal Soriot said the company took the detention of its China president “very seriously”, as the drugmaker raised its guidance for a second straight quarter on the back of ...

AstraZeneca PLC (AZN) reports a 21% revenue increase and upgrades full-year guidance, while navigating potential headwinds in ...